Denomme G A, Smith J W, Kelton J G, Bell D A
Department of Medicine, University Hospital, London, Ontario, Canada.
Blood. 1992 Jan 15;79(2):447-51.
Tonsillar lymphocytes from an otherwise healthy nonthrombocytopenic male child were fused with the lymphoblastoid cell line GM 4672. Twenty of 472 (4%) hybridomas had antiplatelet reactivity detected using intact platelets in an enzyme-linked immunosorbent assay. One hybridoma (STO 171) reacted to platelet glycoprotein IIb (integrin alpha IIb) as determined by radioimmunoprecipitation and immunoblotting. Antibody specificity was confirmed using immunodepletion experiments with isotypic antibodies derived from a mutlitransfused Glanzmann's thrombasthenic patient. The antibody reactivity was restricted to platelets and did not react with other integrin alpha-chain proteins expressed on granulocytes or cultured human brain-derived microvascular endothelial cells. These studies indicate that lymphocytes of normal, nonthrombocytopenic individuals have the genetic potential to produce antiplatelet autoantibodies.
从一名健康非血小板减少的男童获取扁桃体淋巴细胞,并将其与淋巴母细胞系GM 4672融合。在酶联免疫吸附试验中,使用完整血小板检测发现,472个杂交瘤中有20个(4%)具有抗血小板反应性。通过放射免疫沉淀和免疫印迹法确定,一个杂交瘤(STO 171)与血小板糖蛋白IIb(整合素αIIb)发生反应。使用来自多次输血的Glanzmann血小板无力症患者的同型抗体进行免疫去除实验,证实了抗体的特异性。抗体反应性仅限于血小板,不与粒细胞或培养的人脑微血管内皮细胞上表达的其他整合素α链蛋白发生反应。这些研究表明,正常非血小板减少个体的淋巴细胞具有产生抗血小板自身抗体的遗传潜力。